/
/
Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
This content is Free Access.
Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
Chapters
- 00:04Introduction
- 00:52Dissection and Infection of Ex Vivo Pig Lung (EVPL) Tissue
- 04:45Determination of Antibiotic Efficacy
- 06:39Results: Screening Bacterial Isolates for Antibiotic Susceptibility with the EVPL Model
- 08:49Conclusion
This workflow can be used to perform antibiotic susceptibility testing using an established ex vivo model of bacterial biofilm in the lungs of individuals with cystic fibrosis. Use of this model could enhance the clinical validity of MBEC (minimal biofilm eradication concentration) assays.
